Skip to main content

Advertisement

Table 2 Consumption of typical antipsychotics covered by Israel’s national health care system, 2004 – 2013 (defined daily dose per 1000 psychiatric inpatients per day)

From: Trends in the use of antipsychotics in the Israeli inpatient population, 2004–2013

  2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
Perphenazine 1.39 1.55 2.04 2.23 2.39 2.38 1.90 2.57 2.64 2.55
Thioridazine 0.42 0.44 0.27 0.32 0.32 0.31 0.28 0.16 0.15 0.18
Clothiapine 6.37 5.27 8.37 5.83 6.59 5.58 6.66 6.64 5.37 4.63
Levomepromazine 0.77 0.95 0.84 0.7 1.19 0.61 0.82 0.77 0.79 1.05
Fluphenazine 70.25 61.17 58.92 57.69 56.86 58.00 54.74 65.53 56.78 57.56
Propericiazine(Periciazine) 0.12 0.14 0.12 0.18 0.22 0.16 0.15 0.13 0.18 0.17
Chlorpromazine 4.00 4.41 3.90 3.31 4.02 3.65 3.69 3.40 3.05 1.52
Haloperidol 42.37 42.31 37.64 45.34 45.75 47.32 45.83 49.04 40.63 38.95
Flupentixol 0.45 0.32 0.25 0.26 0.28 0.18 1.76 0.29 0.11 0.15
Zuclopenthixol 21.05 14.26 16.26 18.79 18.83 19.09 17.59 19.21 17.94 17.58
Pimozide 0.03 0.01 0.07 0.15 0.13 0.12 0.12 0.12 0.01 0.24
Sulpiride 1.40 1.56 2.59 1.58 1.53 1.59 1.10 1.03 1.16 0.99
Total 148.62 132.39 131.27 136.38 138.11 138.99 134.64 148.89 128.81 125.57